Taurolock Urokinase™

Home » Taurolock Urokinase™

Catheter lock solution with double effectiveness

TauroLock™ is a preventive lock solution suitable for central venous access within haemodialysis and oncology. In order to ensure a catheter with an optimum blood flow, it is important that the lock solution ensures both clotting and infection prevention. Taurolock’s double effectiveness prevents catheter infections and clot formation.

The double effectiveness of TauroLock Urokinase consists of the combination of:

  • Taurolidine, prevents bacterial growth and biofilm formation
  • 4% citrate, anti-clotting effect
  • Urokinase 5000 units per mL, intensive anti-clotting effect

Besides solving flow problems through the urokinase, TauroLock Urokinase also prevents new formation of clots.

Description

4% citrate (anti-clotting effect), 1.35% taurolidine (broad antimicrobial activity incl. MRSA and VRE) and 5000 IU/mL urokinase (intensive anticoagulant)

Appearance

5 ml glass ampoule, vial with lyophilised urokinase injection powder

Package size:

Combination of 5 ampoules and 5 vials each per box

Z-index number:

15716309

Item number:

1000460

Manufacturer:

Tauropharm

Images:

logo Cablon